产品名称 | Tofacitinib citrate - CP 690550-10 |
产品货号 | Axon 2072 CAS [540737-29-9] MF C16H20N6O.C6H8O7MW 504.49 Purity: 99% Soluble in DMSO Description Potent Janus Kinase 3 (JAK3) inhibitor; an immunosuppressive agent exhibiting potent effects in preclinical transplantation and arthritis models; clinically safe and effective in preventing transplant rejection and improving symptoms of rheumatoid arthritis and psoriasis; the citrate salt form of CP 690550 - Tofacitinib (Axon 1338) References Certificates Categories Extra info AC Papageorgiou et al. Is JAK3 a new drug target for immunomodulation-based therapies? Trends Pharmacol. Sci. 2004, 25(11), 558-562. E Kudlacz et al. The novel JAK-3 inhibitor CP-690550 is a potent immunosuppressive agent in various murine models. Am. J. Transplant. 2004, 4, 51-57. E Kudlacz et al. The JAK-3 inhibitor CP-690550 is a potent anti-inflammatory agent in a murine model of pulmonary eosinophilia. Eur. J. Pharmacol. 2008, 582, 154-161. PS Changelian et al. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor. Sci. 2003, 302(5646), 875-878. Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology Epigenetics Immunology Pain & Inflammation Immunomodulator JAK-STAT EC 2.7.10.2 JAK Pfizer Licensed Products Potent Janus Kinase 3 (JAK3) inhibitor Chemical name 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate Source information Pfizer compound; Sold for research purposes under agreement from Pfizer Inc. Parent CAS No. [477600-75-2] Order Size Unit Price Stock 10 mg €115.00 In Stock |
产品价格 | 现货询价,电话:010-67529703 |
产品规格 | |
产品品牌 | axonmedchem |
产品概述 | |
产品详情 |
Tofacitinib citrate - CP 690550-10Axon 2072 CAS [540737-29-9] MF C16H20N6O.C6H8O7
DescriptionPotent Janus Kinase 3 (JAK3) inhibitor; an immunosuppressive agent exhibiting potent effects in preclinical transplantation and arthritis models; clinically safe and effective in preventing transplant rejection and improving symptoms of rheumatoid arthritis and psoriasis; the citrate salt form of CP 690550 - Tofacitinib (Axon 1338)
Potent Janus Kinase 3 (JAK3) inhibitor
Chemical name3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate Source informationPfizer compound; Sold for research purposes under agreement from Pfizer Inc.Parent CAS No.[477600-75-2] |
产品资料 |